S&P 500   3,266.76 (+0.62%)
DOW   26,917.62 (+0.38%)
QQQ   268.49 (+1.17%)
AAPL   110.76 (+2.35%)
MSFT   206.39 (+1.57%)
FB   250.60 (+0.43%)
GOOGL   1,423.94 (+0.08%)
AMZN   3,050.00 (+1.00%)
TSLA   407.30 (+5.03%)
NVDA   504.58 (+2.16%)
BABA   268.06 (-0.62%)
CGC   13.95 (-2.24%)
GE   6.05 (-0.17%)
MU   48.44 (-2.08%)
AMD   76.69 (+1.15%)
T   27.81 (-0.82%)
F   6.58 (-1.20%)
ACB   4.99 (-4.04%)
GILD   61.99 (-0.42%)
NFLX   475.42 (+0.49%)
DIS   122.23 (-0.21%)
BAC   23.20 (-0.60%)
BA   150.68 (+3.17%)
S&P 500   3,266.76 (+0.62%)
DOW   26,917.62 (+0.38%)
QQQ   268.49 (+1.17%)
AAPL   110.76 (+2.35%)
MSFT   206.39 (+1.57%)
FB   250.60 (+0.43%)
GOOGL   1,423.94 (+0.08%)
AMZN   3,050.00 (+1.00%)
TSLA   407.30 (+5.03%)
NVDA   504.58 (+2.16%)
BABA   268.06 (-0.62%)
CGC   13.95 (-2.24%)
GE   6.05 (-0.17%)
MU   48.44 (-2.08%)
AMD   76.69 (+1.15%)
T   27.81 (-0.82%)
F   6.58 (-1.20%)
ACB   4.99 (-4.04%)
GILD   61.99 (-0.42%)
NFLX   475.42 (+0.49%)
DIS   122.23 (-0.21%)
BAC   23.20 (-0.60%)
BA   150.68 (+3.17%)
S&P 500   3,266.76 (+0.62%)
DOW   26,917.62 (+0.38%)
QQQ   268.49 (+1.17%)
AAPL   110.76 (+2.35%)
MSFT   206.39 (+1.57%)
FB   250.60 (+0.43%)
GOOGL   1,423.94 (+0.08%)
AMZN   3,050.00 (+1.00%)
TSLA   407.30 (+5.03%)
NVDA   504.58 (+2.16%)
BABA   268.06 (-0.62%)
CGC   13.95 (-2.24%)
GE   6.05 (-0.17%)
MU   48.44 (-2.08%)
AMD   76.69 (+1.15%)
T   27.81 (-0.82%)
F   6.58 (-1.20%)
ACB   4.99 (-4.04%)
GILD   61.99 (-0.42%)
NFLX   475.42 (+0.49%)
DIS   122.23 (-0.21%)
BAC   23.20 (-0.60%)
BA   150.68 (+3.17%)
S&P 500   3,266.76 (+0.62%)
DOW   26,917.62 (+0.38%)
QQQ   268.49 (+1.17%)
AAPL   110.76 (+2.35%)
MSFT   206.39 (+1.57%)
FB   250.60 (+0.43%)
GOOGL   1,423.94 (+0.08%)
AMZN   3,050.00 (+1.00%)
TSLA   407.30 (+5.03%)
NVDA   504.58 (+2.16%)
BABA   268.06 (-0.62%)
CGC   13.95 (-2.24%)
GE   6.05 (-0.17%)
MU   48.44 (-2.08%)
AMD   76.69 (+1.15%)
T   27.81 (-0.82%)
F   6.58 (-1.20%)
ACB   4.99 (-4.04%)
GILD   61.99 (-0.42%)
NFLX   475.42 (+0.49%)
DIS   122.23 (-0.21%)
BAC   23.20 (-0.60%)
BA   150.68 (+3.17%)
Log in
NASDAQ:PROG

Progenity Stock Forecast, Price & News

$8.66
+0.13 (+1.52 %)
(As of 09/25/2020 11:01 AM ET)
Add
Compare
Today's Range
$8.66
Now: $8.66
$8.75
50-Day Range
$7.71
MA: $8.91
$9.60
52-Week Range
$7.63
Now: $8.66
$15.92
Volume852 shs
Average Volume134,919 shs
Market Capitalization$391.12 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 4.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.67 out of 5 stars


Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PROG
CUSIPN/A
CIKN/A
Phone855-293-2639

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees676
Market Cap$391.12 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$8.66
+0.13 (+1.52 %)
(As of 09/25/2020 11:01 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PROG News and Ratings via Email

Sign-up to receive the latest news and ratings for PROG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Progenity (NASDAQ:PROG) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Progenity?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Progenity in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Progenity
.

When is Progenity's next earnings date?

Progenity is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Progenity
.

How were Progenity's earnings last quarter?

Progenity (NASDAQ:PROG) released its quarterly earnings results on Thursday, August, 13th. The company reported ($6.11) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.83) by $5.28. The firm had revenue of $17.27 million for the quarter, compared to analyst estimates of $26.35 million.
View Progenity's earnings history
.

What price target have analysts set for PROG?

4 brokerages have issued 12-month price targets for Progenity's shares. Their forecasts range from $11.00 to $17.00. On average, they anticipate Progenity's share price to reach $13.75 in the next twelve months. This suggests a possible upside of 58.8% from the stock's current price.
View analysts' price targets for Progenity
.

Who are some of Progenity's key competitors?

What other stocks do shareholders of Progenity own?

Who are Progenity's key executives?

Progenity's management team includes the following people:
  • Dr. Harry Stylli, Founder, CEO & Chairman (Age 58, Pay $395k)
  • Dr. Matthew T. Cooper M.B.A., Ph.D., Chief Scientific Officer (Age 47, Pay $393.71k)
  • Mr. Sami Shihabi M.B.A., M.S., Chief Commercial Officer (Age 49, Pay $415.52k)
  • Mr. Eric d'Esparbes, Sr. VP & CFO (Age 52)
  • Mr. Damon Silvestry, Chief Operating Officer (Age 52)

When did Progenity IPO?

(PROG) raised $100 million in an initial public offering on Friday, June 19th 2020. The company issued 6,700,000 shares at $14.00-$16.00 per share. Piper Sandler and Wells Fargo Securities acted as the underwriters for the IPO and Baird, Raymond James and BTIG were co-managers.

What is Progenity's stock symbol?

Progenity trades on the NASDAQ under the ticker symbol "PROG."

When does Progenity's lock-up period expire?

Progenity's lock-up period expires on Wednesday, December 16th. Progenity had issued 6,666,667 shares in its initial public offering on June 19th. The total size of the offering was $100,000,005 based on an initial share price of $15.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Who are Progenity's major shareholders?

Progenity's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Neuberger Berman Group LLC (14.48%), RTW Investments LP (0.61%), Avidity Partners Management LP (0.53%), Hound Partners LLC (0.49%), Schonfeld Strategic Advisors LLC (0.42%) and Federated Hermes Inc. (0.22%).

Which institutional investors are buying Progenity stock?

PROG stock was purchased by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, RTW Investments LP, Avidity Partners Management LP, Hound Partners LLC, Schonfeld Strategic Advisors LLC, Federated Hermes Inc., Alyeska Investment Group L.P., and Goldman Sachs Group Inc..

How do I buy shares of Progenity?

Shares of PROG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Progenity's stock price today?

One share of PROG stock can currently be purchased for approximately $8.66.

How big of a company is Progenity?

Progenity has a market capitalization of $391.12 million. Progenity employs 676 workers across the globe.

What is Progenity's official website?

The official website for Progenity is www.progenity.com.

How can I contact Progenity?

Progenity's mailing address is 4330 LA JOLLA VILLAGE DRIVE SUITE 200, SAN DIEGO CA, 92122. The company can be reached via phone at 855-293-2639 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.